GGrantIndex
Sort

261,768 grants matching gene therapy

Rapid detection of pathogens and antimicrobial susceptibility directly in patient samples

$910,291
Sadanand Gite · First Light Diagnostics , Inc. · R01 · FY2016 · AI

Defining the Role of Tumor-Neutral Crosstalk in head and Neck Cancer Progression and Treatment Resistance

$910,254
Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA

National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers

$910,251
Terry J Watnick · University Of Maryland Baltimore · U24 · FY2024 · DK

Improved Diagnosis and Treatment of Cushing's Disease

$910,180
Prashant Chittiboina · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS

Lead optimization of a novel cyclic aryl-indole efflux pump inhibitor (EPI) series in combination with levofloxacin against Pseudomonas aeruginosa

$910,179
Ajit K Parhi · Taxis Pharmaceuticals, Inc. · R44 · FY2024 · AI

Substance Use and Immunity in HIV+ Adolescents by Systems Biology

$910,091
Maureen M Goodenow · University Of Florida · R01 · FY2011 · DA

Center for Latino Health Research Opportunities CLaRO

$910,000
Victoria B Mitrani · University Of Miami Coral Gables · U54 · FY2022 · MD

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques

$909,998
Guido Silvestri · Emory University · R01 · FY2022 · AI

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques

$909,998
Guido Silvestri · Emory University · R01 · FY2024 · AI

Optimizing AAV delivery of bNAbs for HIV prevention

$909,998
Matthew Ryan Gardner · Emory University · R01 · FY2023 · AI

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques

$909,998
Guido Silvestri · Emory University · R01 · FY2021 · AI

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques

$909,998
Guido Silvestri · Emory University · R01 · FY2023 · AI

Major Project 1

$909,928
Christopher H Contag · Stanford University · U54 · FY2010 · CA

Animal Models of Diabetic Vascular Disease

$909,910
Rockefeller University · U01 · FY2004 · HL

Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host

$909,837
Ronald Levy · Stanford University · R35 · FY2017 · CA

Illuminating the APOE Locus with Long-Read Sequencing and Targeted Genomics

$909,797
Michael D Greicius · Stanford University · R35 · FY2024 · AG

Functional Analysis of Oncogenic Networks in Primary Organoids

$909,785
Calvin J Kuo · Stanford University · U01 · FY2016 · CA

Human Monoclonal Antibodies Against Cancer

$909,717
Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

IMPACT OF FARMING ENVIRONMENT ON IMMUNE MATURATION AND RESPIRATORY HEALTH

$909,632
James E. Gern · University Of Wisconsin-Madison · U19 · FY2014 · AI

GENE TRANSFER TO THE NERVOUS SYSTEM

$909,605
University Of Florida · P01 · FY2000 · NS

Targeting a Novel Hematopoietic Stem Cell Population in Non-Human Primates for Effective and Sustained Gene Therapy

$909,598
Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2018 · AI

TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis

$909,583
Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2020 · CA

Altering Cardiac Cell Fate for Heart Repair

$909,501
Li Qian · Univ Of North Carolina Chapel Hill · R35 · FY2024 · HL

Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level

$909,471
Anthony Rosenzweig · Massachusetts General Hospital · R35 · FY2022 · HL

Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level

$909,471
Anthony Rosenzweig · Massachusetts General Hospital · R35 · FY2021 · HL